相关实验视频
Updated: Jun 30, 2025
06:47
Microfluidics in Assessing Platelet Function
Published on: November 8, 2024
853
对抗血小板聚合的L-奎布拉基托尔衍生物的合成和评估
Peng-Cheng Cai1, Xin-Jie Liang1, Qi-Xun Feng1
1Key Laboratory of Structure-Based Drug Design and Discovery of Ministry of Education, School of Pharmaceutical Engineering, Shenyang Pharmaceutical University, Shenyang 110016, China.
Journal of Asian natural products research
|March 21, 2024
概括
合成了L-(-) - 奎布拉基托尔衍生物来对抗血栓形成. 化合物3a表现出类似阿司匹林的抗凝剂作用,而4b在老鼠中表现出优异的,剂量独立的抑制作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 自然产品 化学 化学
- 心血管研究研究心血管研究
背景情况:
- 血栓形成是心血管和脑血管疾病的主要原因之一.
- 昆布拉基托 (L-(-) - 昆布拉基托 (QCT) 是一种具有抗血小板聚合特性的天然产品.
- QCT可以抑制PAF受体并减少因印梅他素引起的胃损伤.
研究的目的:
- 为了合成新的L-(-) - 奎布拉基托尔衍生物.
- 为了研究这些衍生物的抗血小板聚合效应.
- 为了识别有力的新型抗血栓剂.
主要方法:
- 合成了五种QCT衍生物.
- 对血小板聚合的抑制作用的评估.
- 在老鼠模型中评估抗凝剂活性.
主要成果:
- 化合物3a表现出与阿司匹林相当的抗凝剂作用.
- 化合物4b在老鼠中表现出剂量独立的抑制活性.
- 在老鼠中,4b化合物的抑制活性比阿司匹林更强.
结论:
- QCT衍生物显示出作为抗血栓剂的前景.
- 化合物3a和4b是血小板聚合的强有力的抑制剂.
- 对QCT衍生物的进一步研究可能会导致新的心血管和脑血管疾病治疗方法.
相关概念视频
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
522
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
522
01:28Structure-Activity Relationships and Drug Design
716
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
716